Compounds > indirubin-3'-monoxime
Page last updated: 2024-10-29

indirubin-3'-monoxime and Hepatocellular Carcinoma

indirubin-3'-monoxime has been researched along with Hepatocellular Carcinoma in 2 studies

indirubin-3'-monoxime: has antiangiogenic activity
indirubin-3'-monoxime : A member of the class of biindoles that is indirubin in which the keto group at position 3' has undergone condensation with hydroxylamine to form the corresponding oxime.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tanaka, T2
Ohashi, S1
Saito, H1
Wada, T1
Aoyama, T1
Ichimaru, Y1
Miyairi, S1
Kobayashi, S2
Kasai, M1

Other Studies

2 other studies available for indirubin-3'-monoxime and Hepatocellular Carcinoma

ArticleYear
Indirubin 3'-oxime inhibits anticancer agent-induced YB-1 nuclear translocation in HepG2 human hepatocellular carcinoma cells.
    Biochemical and biophysical research communications, 2018, 01-29, Volume: 496, Issue:1

    Topics: Active Transport, Cell Nucleus; Angiogenesis Inhibitors; Antineoplastic Agents; Carcinoma, Hepatocel

2018
Mechanism responsible for inhibitory effect of indirubin 3'-oxime on anticancer agent-induced YB-1 nuclear translocation in HepG2 human hepatocellular carcinoma cells.
    Experimental cell research, 2018, 09-15, Volume: 370, Issue:2

    Topics: Antineoplastic Agents; beta Karyopherins; Carcinoma, Hepatocellular; Cell Nucleus; Hep G2 Cells; Hum

2018